Patient Square Capital LP
Patient Square Capital LP reported 23 positions worth $626.7M as of September 30, 2026 (13F filed November 10, 2026). Largest holding: ROIV (45.0%). Biggest move: reduce ONC ($20.7M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | ROIV | $282.0M | 45.00% | 7,710,928 | — | — | +5.6% | |
| ▸ 2 | RVMD | $40.2M | 6.42% | 196,000 | — | — | -18.7% | |
| ▸ 3 | UTHR | $34.0M | 5.42% | 62,677 | — | — | +8.5% | |
| ▸ 4 | ARGX | $26.8M | 4.28% | 28,000 | — | — | -0.8% | |
| ▸ 5 | PHVS | $25.7M | 4.09% | 808,644 | — | — | +2.3% | |
| ▸ 6 | ABVX | $24.1M | 3.84% | 243,000 | — | — | — | |
| ▸ 7 | BLTE | $22.4M | 3.57% | 131,700 | — | — | -4.3% | |
| ▸ 8 | MIRM | $20.0M | 3.19% | 234,000 | — | — | +7.1% | |
| ▸ 9 | ZLAB | $15.6M | 2.49% | 591,510 | — | — | -10.9% | |
| ▸ 10 | DFTX | $14.7M | 2.34% | 385,000 | — | — | -20.8% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Patient Square Capital LP hold as of Q3 2026?
Patient Square Capital LP reported 23 positions worth $626.7M in its Q3 2026 13F filing. Largest positions: ROIV (45.0%), RVMD (6.4%), UTHR (5.4%), ARGX (4.3%) and PHVS (4.1%).
What did Patient Square Capital LP buy in Q3 2026?
New positions: ZLAB, DFTX, CMPS, PCVX and ZNTL (6 in all). Added to: UTHR, ARGX, PHVS, KYMR and BLTE (8 in all).
What did Patient Square Capital LP sell in Q3 2026?
Reduced: ONC, RVMD, ROIV, BNTX and IVA (8 in all). Sold out entirely: XENE, DNTH, EYPT, ARQT and CCCC (6 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.